Spotlight Series on Hepatitis C


Test for HIV, Hepatitis C and Hepatitis B Approved by FDA

January 17, 2015

On Jan. 9, the U.S. Food and Drug Administration (FDA) approved a three-in-one test that detects HIV, hepatitis C and hepatitis B.

The test, manufactured by Roche, is the second version of the "cobas TaqScreen MPX Test." This updated version provides increased sensitivity and is the only test approved by the FDA to detect the three aforementioned viruses together.

The real-time, multi-dye PCR assay will be used to test "donations of human whole blood and blood components including source plasma," according to Roche's press release.

"The combination of viral target detection and identification steps on a fully automated system offers workflow advantages to blood and plasma testing centers by eliminating the need for consecutive rounds of testing, and facilitating earlier donor counseling in the event of a positive result," the manufacturer stated.

Warren Tong is the senior science editor for and

Follow Warren on Twitter: @WarrenAtTheBody.

Copyright © 2015 Remedy Health Media, LLC. All rights reserved.

This article was provided by TheBodyPRO.

No comments have been made.

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read's Comment Policy.)

Your Name:

Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining:


The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.